Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2021 | Updates in radiotherapy for prostate cancer

Robert Jones, MD, PhD, University of Glasgow & Beatson West of Scotland Cancer Centre, Glasgow, UK, shares an overview of the latest developments in radiotherapy for prostate cancer. Prof. Jones highlights the SAKK 09/10 randomized Phase III study (NCT01272050) investigating dose intensification in the salvage therapy setting, and a study investigating the potential of using genomic prognostic scores to reduce the use of androgen deprivation therapy for patients with intermediate- and poor-risk organ-confined disease. This interview took place during the 2021 Genitourinary Cancers Symposium.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.